The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: a case series of six patients in one institution [Corrigendum]
Authors Wang Y, Min L, Zhou Y, Tang F, Luo Y, Zhang W, Duan H, Tu C
Received 21 May 2019
Accepted for publication 21 May 2019
Published 31 May 2019 Volume 2019:11 Pages 5019—5020
Wang Y, Min L, Zhou Y, et al. Cancer Manag Res. 2019;11:3583–3591.
The authors have advised that in Table 4 on page 3588, they incorrectly listed the number of patients who suffered with Hypothyroidism (Grade 2). The listed number of patients in the Grade 2 section for Hypothyroidism should be “1” instead of “2”.
Also, on page 3588 in Table 4, the text “2” should instead just read “2”.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]